Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer

A promising option as the treatment of choice for premenopausal patients with locally advanced or metastatic breast cancer (MBC) could be the combination of a luteinizing hormone-releasing hormone analog and an aromatase inhibitor. However, no prospective studies on the efficacy of goserelin with ex...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Wang, Jiayu, Xu, Binghe, Yuan, Peng, Ma, Fei, Li, Qing, Zhang, Pin, Cai, Ruigang, Fan, Ying, Luo, Yang, Li, Qiao
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2015
Témata:
5600
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504532/
https://ncbi.nlm.nih.gov/pubmed/26131799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky